https://www.wacoca.com/videos/2637122/voice-actress/ 《辟邪除妖 Variants Daphne》人員陸續逝去,充滿各種威脅的奈洛 #Daphne人員陸續逝去充滿各種威脅的奈洛 #Variants #Vlog #VoiceActress #声優 #女性声優 #石川由依 #辟邪除妖
https://www.wacoca.com/videos/2637122/voice-actress/ 《辟邪除妖 Variants Daphne》人員陸續逝去,充滿各種威脅的奈洛 #Daphne人員陸續逝去充滿各種威脅的奈洛 #Variants #Vlog #VoiceActress #声優 #女性声優 #石川由依 #辟邪除妖
Large-scale computational #modelling of #H5 #influenza #variants against #HA1-neutralising #antibodies, https://etidiohnew.blogspot.com/2025/03/large-scale-computational-modelling-of.html
Second time #CDC has reported estimates for more than two regions at a time since October.
To be clear, national data used for chart above are modeled on regional data collection.
LP.8.1 now estimated at majority in Great Lakes, nearing majority in NY/NJ and Mid-Atlantic.
XEC (incl. XEC.4) still around a quarter share in all three regions.
[For color key, see: https://covid.cdc.gov/covid-data-tracker/#variant-proportions]
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #WearAMask #BetterMasks
A FLuQE wavelet opened September, cresting as KP.3.1.1 / MC wave into November. FDA's second-guess vaccine target, KP.2, dropped out in December. Updated #CDC estimates indicate we've been in a JN.1.11 soup pretty much since then.
No new variants broken out by CDC, as KP.1.1.3 / LP descendant LP.8.1 approaches majority.
No recent GISAID data—as Raj's dashboard hasn't updated in near a month.
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis
Stanford researchers develop dual-antibody treatment for ALL SARS-CoV-2 variants — https://www.science.org/doi/10.1126/scitranslmed.adq5720
#HackerNews #StanfordResearchers #DualAntibody #Treatment #SARSCoV2 #Variants #COVID19 #ScienceNews
#XBB.1.5 monovalent #vaccine induces lasting cross-reactive responses to #SARS-CoV-2 #variants such as HV.1 and #JN1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific #antibodies, https://etidiohnew.blogspot.com/2025/03/xbb15-monovalent-vaccine-induces.html
Evolutionary Studies on the #Coxsackievirus A24 #Variants Causing Acute #Hemorrhagic #Conjunctivitis with Emphasis on the Recent #Outbreak of 2023 in #India, https://etidiohnew.blogspot.com/2025/03/evolutionary-studies-on-coxsackievirus.html
Frequency, kinetics and determinants of viable #SARSCoV2 in #bioaerosols from ambulatory #COVID19 patients infected with the Beta, Delta or Omicron #variants
https://www.nature.com/articles/s41467-024-45400-1
> Half of Covid-19 patients emitted infectious virus in respiratory particles smaller than 5 microns (>30 min to settle out). Culturability of aerosols was associated with lower neutralizing antibody titers, so immune response matters for transmission potential.
#CDC has long time now been piloting the craft of #PublicHealth sans navigational equipment.
To be clear, national data used for chart above are modeled on regional data collection.
Given little data we do have, LP.8.1 now estimated as nearing majority status in NY/NJ, with XEC (incl. XEC.4) still near a third share.
As for other regions?
[For color key, see: https://covid.cdc.gov/covid-data-tracker/#variant-proportions]
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #WearAMask #BetterMasks
After January's FLiRT soup (JN.1 and JN.1.11 lineages vying for dominance), we've returned to JN.1.11 soup (FLiRT and FLuQE clusters competing), that began when FLuQE majority ended in November.
#CDC breaks out a new FLuQE variant, MC.28.1, even as being squeezed by LP.8.1 fam.
Raj updated global dashboard Sunday, incl. hundreds of U.S. samples early Feb. Still await updated U.S. dashboard.
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis
Updated GISAID data for late January has FluQE31 KP.3.1.1 / MC and children down to just over a fifth of all sequences.
FLiRT KS.1.1 / FLuQE KP.3.3 hybrid XEC down near two fifths.
LP.8.1 and child LP.8.1.1 / NY together already another fifth.
Meanwhile, in remaining fifth:
• JN.1 FLiRT descendant LF.7 remains diverse despite pressure; and
• XEQ (recombinant of FLiRT KS.1.1.2 and KP.3) continues to stand out.
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne
#CDC has long time now been piloting the craft of #PublicHealth sans navigational equipment.
To be clear, national data used for chart above are modeled on regional data collection.
Given little data we do have, LP.8.1 has gained plurality status in NY/NJ and Great Lakes regions, XEC still majority in Mtn/Dakotas, with cousin XEQ prominent.
[For color key, see: https://covid.cdc.gov/covid-data-tracker/#variant-proportions]
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #WearAMask #BetterMasks
After January's FLiRT soup (JN.1 and JN.1.11 lineages vying for dominance), we've returned to JN.1.11 soup (FLiRT and FLuQE clusters competing), that began when FLuQE majority ended in November.
After no data two weeks ago, #CDC updated variant estimates.
Raj has updated dashboard Sunday with new GISAID sequences. As of data two weeks ago, XEC.8 joins XEC.2 and LP.8.1.1 / NY as significant.
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis